Three-dimensional structure determination lies at the heart of modern drug discovery, mechanistic biology, and protein engineering. Understanding how a protein folds, where substrates and inhibitors bind, and how multi-protein complexes assemble provides the molecular basis for rational therapeutic design.
ICDMO's structural biology platform spans the complete toolkit — from atomic-resolution X-ray crystallography and Cryo-EM through solution-state NMR, rapid SAXS characterization, and fully integrated structure-based drug design. All techniques are delivered under one roof, enabling seamless integrative structural projects.
Each technique provides unique, complementary information. Our scientists guide you to the right approach for your specific target, timeline, and scientific question.
Confirm druggability; identify binding pockets, allosteric sites and conformational flexibility for rational drug design.
Crystallographic screening of 500–1,000 fragment libraries to identify novel chemical starting points for your programme.
Iterative co-crystal structures guide SAR: visualize binding modes, optimize key interactions and improve selectivity.
Capture substrate, transition-state and product complexes to understand catalytic mechanisms and allosteric regulation.
Rational enzyme variant design, antibody humanization, and protein–protein interface engineering guided by atomic structure.
High-quality structures for IND applications, biosimilar comparability studies, and patent binding-mode novelty filings.
Note: Timelines are estimates for well-behaved samples. Challenging targets may require additional optimization. Contact us for a free feasibility assessment before project initiation.
Share your target details and our structural biologists will recommend the best technique and provide a no-obligation project plan within 24 hours.
Contact Us Online Consultation